SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference

/PRNewswire/ -- SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of the central...

Related Keywords

South Korea ,Seoul ,Soult Ukpyolsi ,Boston ,Massachusetts ,United States ,Hyoungrae Cho ,Donghoon Lee ,Dina Albanese ,Corey Strickland ,Source Sk Biopharmaceuticals Co Ltd ,Most Influential Companies ,Sk Biopharmaceuticals Co Ltd ,Sk Group ,Sk Life Science Inc ,Sk Inc ,Proteovant Therapeutics ,Annual Discovery ,Target Conference ,Target Meeting Presentations ,Novel Platform ,Molecular Glues ,Molecular Glue Degrader ,Influential Companies ,Sk Biopharmaceuticals Co ,Td ,